Search Results - dennis+slamon

2 Results Sort By:
2021-244 MOCETINOSTAT IN COMBINATION WITH CHEMOTHERAPY TO TREAT RHABDOMYOSARCOMA
SUMMARY: Researchers at UCLA’s David Geffen School of Medicine and the UCLA Sarcoma Program have identified a treatment combination which utilizes Mocetinostat in conjunction with chemotherapy for the selective treatment of rhabdomyosarcoma. BACKGROUND: Sarcomas are a heterogeneous group of tumors arising throughout the body’s connective...
Published: 7/17/2025   |   Updated: 1/26/2022   |   Inventor(s): Arun Singh, Noah Federman, Dennis Slamon
Keywords(s):  
Category(s): Therapeutics, Therapeutics > Oncology, Therapeutics > Oncology > Oncology (Small Molecules), Therapeutics > Sarcoma And Soft Tissue
Biomarkers Of Response And Synergistic Combinations With ERK Targeted Therapies In Human Cancers (UCLA Case No. 2015-289)
Summary UCLA researchers have identified a set of genomic markets that identify a group of human cancer cell lines more likely to respond to ERK1/2 inhibitors. These markers are believed to be critical in identifying those patients that will most likely respond to ERK1/2 inhibition used in cancer therapy. Background Extracellular signal-regulated kinase...
Published: 5/30/2026   |   Updated: 12/18/2019   |   Inventor(s): Dennis Slamon
Keywords(s):  
Category(s): Diagnostic Markers > Targets And Assays